RESEARCH ARTICLE

The Use of Natural Products as an Adjunct in the Treatment of Hypertension: A Case Study with Mango-Ginger Tea

Orien L Tulp, Syed AA Rizvi, Andrew A Sciranka 

College of Medicine and Graduate Studies, University of Science Arts and Technology, Montserrat

Corresponding Author: Orien L Tulp. College of Medicine and Graduate Studies, University of Science Arts and Technology, Montserrat, British West Indies. MSR1110. E-mail: [email protected] 

Received: December 23, 2022                                            Published: January 05, 2023 

Citation: Orien LT. The Use of Natural Products as an Adjunct in the Treatment of Hypertension: A Case Study with Mango-Ginger Tea. Int J Complement Intern Med. 2023;3(1):85–91. DOI: 10. 58349/IJCIM. 1. 3. 2022. 00113 

Copyright: ©2023 Tulp. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Abstract 

A mango leaf-ginger combination was added to the pharmacologic regimen to improve the clinical management of chronic mid-grade hypertension (HTN) in an NIDDM patient with effective glycemic control. Measures of systolic and diastolic blood pressure (SBP and DBP respectively) were obtained for the 4 weeks of control monitoring when taking a multidrug pharmacologic treatment consisting of metoprolol succinate, losartan potassium, and amlodipine (MLA regimen) for 6 months or more, followed by 4 weeks of a mango-leaf+ginger tea (MGT) combination. Measures of systolic (SBP) and diastolic BP (DBP) were obtained 6-12 hours after the multidrug regimen and resulted in a 13% decrease in both SBP and DBP after one week, a 17% reduction in both parameters after two weeks, and a 30% reduction at weeks 3 and 4 of the MGT trial. These results indicate that the addition of the MGT natural product regimen when added to the MLA treatment was contributing to a normalization of BP and an amelioration of HTN when the MLA regimen alone was incompletely effective due to multi-drug resistance or other factors. 

Keywords: Hypertension, Diabetes, Allopathic drugs, Natural Products, Complementary and Alternative Therapies

References 

1. Jameson JL, Fauci A, Kasper DL, et al. Harrison's Principles of Internal Medicine. 20th Ed. McGrw-Hill pubs. 2018. 

2. Njoloma I, Lewis N, Tulp OL, et al. A Primer on Hypertension and on the Racial / Ethnic Disparities in Diagnosis and Management: A Comprehensive Overview. Int J of Family & Community Med. 2021;5(6):229–239. 

3. Rivzi AA, Einstein GP, Tulp OL, et al. Introduction to traditional medicines and their role in prevention and treatment of emerging and re-emerging diseases. Biomolecules. 2022;12:1442–1472. 

4. Tulp OL, Bell A, Einstein GP, et al. Can traditional Chinese medicine formulas treat hypertension effectively? Adv Obes Weight Control Manag. 2021;11(3):72–74. 

5. Michel T, Hofman B. Treatment of myocardial ischemia and hypertension. In: Goodman and Gillman, Textbook of Pharmacology. 12th ed. 2011.p.771–784. 

6. Kumar M, Saurabh V, Tomor M, et al. Mango (Mangifera indica L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities. Antioxidants (Basel). 2021;10(2):299–330. 

7. Johnston C, Ritter S, Jones D, et al. The effects of a magnesium-aspartate supplement on serum magnesium, lactate, and exercise outcome in rats. Faseb J. 1999. 

8. Mao QQ, Xu XY, Cao SY, et al. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe). Foods. 2019;8(6):185. 

9. Bernard RJ, Ugianskis EJ, Martin DA, et al. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J of Cardiol. 1992;69(5). p.440–444. 

10. Prism Graphics, Inc. © 2021. 

11. Lin B, Dai O, Zhau F, et al. Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis. Biomed Pharmacotherapeutics. 2020;132:110855. 

12. Lai X, Dong Z, Wu S, et al. Efficacy and Safety of Chinese Herbal Medicine Compared with Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial. Circulation: Cardiovascular Quality and Outcomes. 2022;15:e007923. 

13. Tulp OL, Chow T, Konyk CM, et al. Western Medicine vs. Oriental Medicine in Hypertension Therapy: Case Study. The FASEB Journal. 2016;30(S1):941.